SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001136261-18-000318
Filing Date
2018-11-21
Accepted
2018-11-21 16:12:26
Documents
4
Period of Report
2018-11-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K body8k.htm 8-K 15356
2 AMENDMENT TO EMPLOYMENT AGREEMENT, DATED NOVEMBER 20, 2018, BY AND BETWEEN JOHN exh10-1.htm EX-10.1 2502
3 LOGO image1904.jpg GRAPHIC 6415
4 LETTERHEAD ptxletterhead8060.jpg GRAPHIC 15480
  Complete submission text file 0001136261-18-000318.txt   49684
Mailing Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960
Business Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960 (862) 260-8457
PERNIX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001024126 (see all company filings)

IRS No.: 330724736 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14494 | Film No.: 181198337
SIC: 2834 Pharmaceutical Preparations